Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Primary prevention

Citations 41-50 of 558 total displayed.

Past content (since Feb 1999):

AHA Scientific Statements
Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis: A Scientific Statement From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Michael A. Gerber, Robert S. Baltimore, Charles B. Eaton, Michael Gewitz, Anne H. Rowley, Stanford T. Shulman, and Kathryn A. Taubert
Circulation 2009;119:1541-1551; published online before print as doi:10.1161/CIRCULATIONAHA.109.191959 [Abstract] [Full text]  

Editorials
Hypercholesterolemia Among Children: When Is It High, and When Is It Really High?
Stephen Cook
Circulation 2009;119:1075-1077, doi:10.1161/CIRCULATIONAHA.108.837666 [Full text]  

Pediatric Cardiology
Concentrations of Low-Density Lipoprotein Cholesterol and Total Cholesterol Among Children and Adolescents in the United States
Earl S. Ford, Chaoyang Li, Guixiang Zhao, and Ali H. Mokdad
Circulation 2009;119:1108-1115; published online before print as doi:10.1161/CIRCULATIONAHA.108.816769 [Abstract] [Full text]  

AHA Scientific Statements
Implementing American Heart Association Pediatric and Adult Nutrition Guidelines: A Scientific Statement From the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research
Samuel S. Gidding, Alice H. Lichtenstein, Myles S. Faith, Allison Karpyn, Julie A. Mennella, Barry Popkin, Jonelle Rowe, Linda Van Horn, and Laurie Whitsel
Circulation 2009;119:1161-1175, doi:10.1161/CIRCULATIONAHA.109.191856 [Full text]  

Articles
Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis. A Scientific Statement From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research
Michael A. Gerber, Robert S. Baltimore, Charles B. Eaton, Michael Gewitz, Anne H. Rowley, Stanford T. Shulman, and Kathryn A. Taubert
Circulation published February 26, 2009, doi:10.1161/CIRCULATIONAHA.109.191959 [Abstract]  

Coronary Heart Disease
Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors
Peter Collins, Lori Mosca, Mary Jane Geiger, Deborah Grady, Marcel Kornitzer, Messan G. Amewou-Atisso, Mark B. Effron, Sherie A. Dowsett, Elizabeth Barrett-Connor, and Nanette K. Wenger
Circulation 2009;119:922-930; published online before print as doi:10.1161/CIRCULATIONAHA.108.817577 [Abstract] [Full text]  

Articles
Concentrations of Low-Density Lipoprotein Cholesterol and Total Cholesterol Among Children and Adolescents in the United States
Earl S. Ford, Chaoyang Li, Guixiang Zhao, and Ali H. Mokdad
Circulation published February 16, 2009, doi:10.1161/CIRCULATIONAHA.108.816769 [Abstract]  

Correspondence
Response to Letter Regarding Article, "Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study"
Dariush Mozaffarian, Curt D. Furberg, Bruce M. Psaty, and David Siscovick
Circulation 2009;119:e196, doi:10.1161/CIRCULATIONAHA.108.830901 [Full text]  

Articles
Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial. Results of Subgroup Analyses by Age and Other Factors
Peter Collins, Lori Mosca, Mary Jane Geiger, Deborah Grady, Marcel Kornitzer, Messan G. Amewou-Atisso, Mark B. Effron, Sherie A. Dowsett, Elizabeth Barrett-Connor, and Nanette K. Wenger
Circulation published February 9, 2009, doi:10.1161/CIRCULATIONAHA.108.817577 [Abstract]  

Special Report
Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop
Emelia J. Benjamin, Peng-Sheng Chen, Diane E. Bild, Alice M. Mascette, Christine M. Albert, Alvaro Alonso, Hugh Calkins, Stuart J. Connolly, Anne B. Curtis, Dawood Darbar, Patrick T. Ellinor, Alan S. Go, Nora F. Goldschlager, Susan R. Heckbert, José Jalife, Charles R. Kerr, Daniel Levy, Donald M. Lloyd-Jones, Barry M. Massie, Stanley Nattel, Jeffrey E. Olgin, Douglas L. Packer, Sunny S. Po, Teresa S.M. Tsang, David R. Van Wagoner, Albert L. Waldo, and D. George Wyse
Circulation 2009;119:606-618, doi:10.1161/CIRCULATIONAHA.108.825380 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56

* Subspecialty Collections Home

* Show  Primary prevention
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment